AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
POLYMERASE-CHAIN-REACTION DETECTION OF HAEMOPHILUS-DUCREYI DNA
Authors: ROESEL DJ GWANZURA L MASON PR JOFFE M KATZENSTEIN DA
Citation: Dj. Roesel et al., POLYMERASE-CHAIN-REACTION DETECTION OF HAEMOPHILUS-DUCREYI DNA, SEXUALLY TRANSMITTED INFECTIONS, 74(1), 1998, pp. 63-65
PROTEASE INHIBITOR THERAPY, HIV-1 RNA, AND CD4-CELL RESPONSE IN A CLINICAL-PRACTICE( T)
Authors: OLSON JE ZOLOPA AR KATZENSTEIN DA
Citation: Je. Olson et al., PROTEASE INHIBITOR THERAPY, HIV-1 RNA, AND CD4-CELL RESPONSE IN A CLINICAL-PRACTICE( T), Journal of investigative medicine, 46(1), 1998, pp. 143-143
HIV-1 REVERSE-TRANSCRIPTASE CODON-215 MUTATION IN PLASMA RNA - IMMUNOLOGICAL AND VIROLOGICAL RESPONSES TO ZIDOVUDINE
Authors: REY D HUGHES M PI JT WINTERS M MERIGAN TC KATZENSTEIN DA
Citation: D. Rey et al., HIV-1 REVERSE-TRANSCRIPTASE CODON-215 MUTATION IN PLASMA RNA - IMMUNOLOGICAL AND VIROLOGICAL RESPONSES TO ZIDOVUDINE, Journal of acquired immune deficiency syndromes and human retrovirology, 17(3), 1998, pp. 203-208
ANTIMICROBIAL RESISTANCE IN GONOCOCCI ISOLATED FROM PATIENTS AND FROMCOMMERCIAL SEX WORKERS IN HARARE, ZIMBABWE
Authors: MASON PR GWANZURA L LATIF AS MAROWA E RAY S KATZENSTEIN DA
Citation: Pr. Mason et al., ANTIMICROBIAL RESISTANCE IN GONOCOCCI ISOLATED FROM PATIENTS AND FROMCOMMERCIAL SEX WORKERS IN HARARE, ZIMBABWE, International journal of antimicrobial agents, 9(3), 1998, pp. 175-179
ESTIMATING HIV INCIDENCE FROM AGE-SPECIFIC PREVALENCE DATA - COMPARISON WITH CONCURRENT COHORT ESTIMATES IN A STUDY OF MALE FACTORY-WORKERS, HARARE, ZIMBABWE
Authors: GREGSON S MACHEKANO R DONNELLY CA MBIZVO MT ANDERSON RM KATZENSTEIN DA
Citation: S. Gregson et al., ESTIMATING HIV INCIDENCE FROM AGE-SPECIFIC PREVALENCE DATA - COMPARISON WITH CONCURRENT COHORT ESTIMATES IN A STUDY OF MALE FACTORY-WORKERS, HARARE, ZIMBABWE, AIDS, 12(15), 1998, pp. 2049-2058
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1998 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL AIDS SOCIETY USA PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1998 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL AIDS SOCIETY USA PANEL, JAMA, the journal of the American Medical Association, 280(1), 1998, pp. 78-86
VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/
Authors: LATHEY JL HUGHES MD FISCUS SA PI T JACKSON JB RASHEED S ELBEIK T REICHMAN R JAPOUR A DAQUILA RT SCOTT W GRIFFITH BP HAMMER SM KATZENSTEIN DA
Citation: Jl. Lathey et al., VARIABILITY AND PROGNOSTIC VALUES OF VIROLOGICAL AND CD4 CELL MEASURES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-INFECTED PATIENTS WITH 200-500 CD4 CELLS MM(3) (ACTG-175)/, The Journal of infectious diseases, 177(3), 1998, pp. 617-624
CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES
Authors: FISCUS SA HUGHES MD LATHEY JL PI T JACKSON JB RASHEED S ELBEIK T REICHMAN R JAPOUR A BYINGTON R SCOTT W GRIFFITH BP KATZENSTEIN DA HAMMER SM
Citation: Sa. Fiscus et al., CHANGES IN VIROLOGICAL MARKERS AS PREDICTORS OF CD4 CELL DECLINE AND PROGRESSION OF DISEASE IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTEDADULTS TREATED WITH NUCLEOSIDES, The Journal of infectious diseases, 177(3), 1998, pp. 625-633
USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY
Authors: MARSCHNER IC COLLIER AC COOMBS RW DAQUILA RT DEGRUTTOLA V FISCHL MA HAMMER SM HUGHES MD JOHNSON VA KATZENSTEIN DA RICHMAN DD SMEATON LM SPECTOR SA SAAG MS
Citation: Ic. Marschner et al., USE OF CHANGES IN PLASMA-LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA TO ASSESS THE CLINICAL BENEFIT OF ANTIRETROVIRAL THERAPY, The Journal of infectious diseases, 177(1), 1998, pp. 40-47
A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS
Authors: WINTERS MA COOLLEY KL GIRARD YA LEVEE DJ HAMDAN H SHAFER RW KATZENSTEIN DA MERIGAN TC
Citation: Ma. Winters et al., A 6-BASEPAIR INSERT IN THE REVERSE-TRANSCRIPTASE GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CONFERS RESISTANCE TO MULTIPLE NUCLEOSIDE INHIBITORS, The Journal of clinical investigation, 102(10), 1998, pp. 1769-1775
AN EVALUATION OF DIPSTICK-DOT IMMUNOASSAY IN THE DETECTION OF ANTIBODIES TO HIV-I AND HIV-2 IN ZIMBABWE
Authors: RAY CS MASON PR SMITH H ROGERS L TOBAIWA O KATZENSTEIN DA
Citation: Cs. Ray et al., AN EVALUATION OF DIPSTICK-DOT IMMUNOASSAY IN THE DETECTION OF ANTIBODIES TO HIV-I AND HIV-2 IN ZIMBABWE, TM & IH. Tropical medicine & international health, 2(1), 1997, pp. 83-88
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1997 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL-AIDS-SOCIETY USA PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1997 - UPDATED RECOMMENDATIONS OF THE INTERNATIONAL-AIDS-SOCIETY USA PANEL, JAMA, the journal of the American Medical Association, 277(24), 1997, pp. 1962-1969
ANTIRETROVIRAL THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN 1997
Authors: KATZENSTEIN DA
Citation: Da. Katzenstein, ANTIRETROVIRAL THERAPY FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN 1997, Western journal of medicine, 166(5), 1997, pp. 319-325
THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-AFFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER (VOL 335, PG 1091, 1996)
Authors: KATZENSTEIN DA
Citation: Da. Katzenstein, THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-AFFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER (VOL 335, PG 1091, 1996), The New England journal of medicine, 337(15), 1997, pp. 1097-1097
NEUROMUSCULAR FUNCTION IN HIV-INFECTION - ANALYSIS OF A PLACEBO-CONTROLLED COMBINATION ANTIRETROVIRAL TRIAL
Authors: SIMPSON DM KATZENSTEIN DA HAMMER SM HUGHES MD WILIAMSON D JIANG Q PI JT
Citation: Dm. Simpson et al., NEUROMUSCULAR FUNCTION IN HIV-INFECTION - ANALYSIS OF A PLACEBO-CONTROLLED COMBINATION ANTIRETROVIRAL TRIAL, Neurology, 48(3), 1997, pp. 66001-66001
SEQUENCE AND DRUG SUSCEPTIBILITY OF SUBTYPE-C REVERSE-TRANSCRIPTASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERTERS IN ZIMBABWE
Authors: SHAFER RW EISEN JA MERIGAN TC KATZENSTEIN DA
Citation: Rw. Shafer et al., SEQUENCE AND DRUG SUSCEPTIBILITY OF SUBTYPE-C REVERSE-TRANSCRIPTASE FROM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SEROCONVERTERS IN ZIMBABWE, Journal of virology, 71(7), 1997, pp. 5441-5448
DIVERGENT TRANSCRIPTIONAL REGULATION AMONG EXPANDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUBTYPES
Authors: MONTANO MA NOVITSKY VA BLACKARD JT CHO NL KATZENSTEIN DA ESSEX M
Citation: Ma. Montano et al., DIVERGENT TRANSCRIPTIONAL REGULATION AMONG EXPANDING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 SUBTYPES, Journal of virology, 71(11), 1997, pp. 8657-8665
RISK-FACTORS FOR HIV-INFECTION AT ENROLLMENT IN AN URBAN MALE FACTORYCOHORT IN HARARE, ZIMBABWE
Authors: BASSETT MT MCFARLAND WC RAY S MBIZVO MT MACHEKANO R VANDEWIJGERT JHHM KATZENSTEIN DA
Citation: Mt. Bassett et al., RISK-FACTORS FOR HIV-INFECTION AT ENROLLMENT IN AN URBAN MALE FACTORYCOHORT IN HARARE, ZIMBABWE, Journal of acquired immune deficiency syndromes and human retrovirology, 13(3), 1996, pp. 287-293
ANTIMICROBIAL SUSCEPTIBILITY PATTERNS AMONGST GROUP-B STREPTOCOCCI FROM WOMEN IN HARARE, ZIMBABWE
Authors: MASON PR GWANZURA L LATIF AS RAY S VANDEWIJGERT J KATZENSTEIN DA
Citation: Pr. Mason et al., ANTIMICROBIAL SUSCEPTIBILITY PATTERNS AMONGST GROUP-B STREPTOCOCCI FROM WOMEN IN HARARE, ZIMBABWE, International journal of antimicrobial agents, 7(1), 1996, pp. 29-32
ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1996 - RECOMMENDATIONS OFAN INTERNATIONAL PANEL
Authors: CARPENTER CCJ FISCHL MA HAMMER SM HIRSCH MS JACOBSEN DM KATZENSTEIN DA MONTANER JSG RICHMAN DD SAAG MS SCHOOLEY RT THOMPSON MA VELLA S YENI PG VOLBERDING PA
Citation: Ccj. Carpenter et al., ANTIRETROVIRAL THERAPY FOR HIV-INFECTION IN 1996 - RECOMMENDATIONS OFAN INTERNATIONAL PANEL, JAMA, the journal of the American Medical Association, 276(2), 1996, pp. 146-154
A TRIAL COMPARING NUCLEOSIDE MONOTHERAPY WITH COMBINATION THERAPY IN HIV-INFECTED ADULTS WITH CD4 CELL COUNTS FROM 200 TO 500 PER CUBIC MILLIMETER
Authors: HAMMER SM KATZENSTEIN DA HUGHES MD GUNDACKER H SCHOOLEY RT HAUBRICH RH HENRY WK LEDERMAN MM PHAIR JP NIU M HIRSCH MS MERIGAN TC BLASCHKE TF SIMPSON D MCLAREN C ROONEY J SALGO M
Citation: Sm. Hammer et al., A TRIAL COMPARING NUCLEOSIDE MONOTHERAPY WITH COMBINATION THERAPY IN HIV-INFECTED ADULTS WITH CD4 CELL COUNTS FROM 200 TO 500 PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1081-1090
THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-INFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER
Authors: KATZENSTEIN DA HAMMER SM HUGHES MD GUNDACKER H JACKSON JB FISCUS S RASHEED S ELBEIK T REICHMAN R JAPOUR A MERIGAN TC HIRSCH MS
Citation: Da. Katzenstein et al., THE RELATION OF VIROLOGICAL AND IMMUNOLOGICAL MARKERS TO CLINICAL OUTCOMES AFTER NUCLEOSIDE THERAPY IN HIV-INFECTED ADULTS WITH 200 TO 500 CD4 CELLS PER CUBIC MILLIMETER, The New England journal of medicine, 335(15), 1996, pp. 1091-1098
POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 AND THYMOSIN ALPHA(1) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: RAMACHANDRAN R KATZENSTEIN DA WINTERS MA KUNDU SK MERIGAN TC
Citation: R. Ramachandran et al., POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 AND THYMOSIN ALPHA(1) IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 173(4), 1996, pp. 1005-1008
DEFERRAL OF BLOOD-DONORS WITH RISK-FACTORS FOR HIV-INFECTION SAVES LIVES AND MONEY IN ZIMBABWE
Authors: MCFARLAND W KAHN JG KATZENSTEIN DA MVERE D SHAMU R
Citation: W. Mcfarland et al., DEFERRAL OF BLOOD-DONORS WITH RISK-FACTORS FOR HIV-INFECTION SAVES LIVES AND MONEY IN ZIMBABWE, Journal of acquired immune deficiency syndromes and human retrovirology, 9(2), 1995, pp. 183-192
THE ASSOCIATION BETWEEN HIV PHENOTYPE, VIRUS BURDEN, CODON-215 MUTATION AND CD4 CELL DECLINE - REPLY
Authors: KOZAL MJ SHAFER RW WINTERS MA KATZENSTEIN DA HALPERN J MERIGAN TC
Citation: Mj. Kozal et al., THE ASSOCIATION BETWEEN HIV PHENOTYPE, VIRUS BURDEN, CODON-215 MUTATION AND CD4 CELL DECLINE - REPLY, Journal of acquired immune deficiency syndromes and human retrovirology, 9(1), 1995, pp. 101-102
Risultati: 1-25 | 26-35